Skip to main content

Serious fungal infections in Egypt

European Journal of Clinical Microbiology & Infectious Diseases volume 36, pages 971–974 (2017)Cite this article

Abstract

We aimed to estimate the burden of serious fungal infections in Egypt, currently unknown, based on the size of the populations at risk and available epidemiological data. Data were obtained from the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and published reports with clearcut denominators. When no data existed, risk populations were used to estimate frequencies of fungal infections, using previously described methodology. The population of Egypt in 2011 was ∼82,500,000; 31% children, and 8% women >60 years of age. Amongst about 21.8 million women aged 15–50 years, recurrent vulvovaginal candidiasis (≥4 episodes/year) is estimated to occur in 1.3 million (3,169/100,000 females). Using a low international average rate of 5/100,000, we estimate 4,127 cases of candidaemia, and 619 patients with intra-abdominal candidiasis. Amongst the survivors of pulmonary tuberculosis (TB) in Egypt in 2012, 319 new cases of chronic pulmonary aspergillosis (CPA) are likely, a prevalence of 1,005 post-TB and a total prevalence estimate of 3,015 CPA patients in all. Asthma is common in Egypt, affecting 9.4% of adults, 5.35 million, and so ABPA and SAFS were estimated in around 162/100,000 and 214/100,000 respectively. Invasive aspergillosis is estimated to affect 495 patients following leukaemia therapy, there are an estimated 37 cases in renal and liver transplant recipients, and an estimated 132 patients develop IA in the context of lung cancer. Amongst 641,000 COPD admissions to hospital each year, 8,337 patients develop IA. The total HIV-infected population is small, with an estimated 6,500 patients, 2,500 not on antiretroviral therapy. Amongst HIV-infected patients, 38 (0.6%) cases of cryptococcal meningitis and 125 (1.9%) cases of Pneumocystis pneumonia are estimated each year. Fungal keratitis is common, with 28–55% (mean 40%) of corneal infections being fungal, an estimated total of 11,550 cases. The present study indicates that 2% of the Egyptian population is affected by fungal infections. The estimates are certainly incomplete, and need further epidemiological and diagnostic studies.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Global Action Fund for Fungal Infections (2015) “95–95 by 2025” Improving outcomes for patients with fungal infections across the world: a roadmap for the next decade. May 2015. http://www.gaffi.org/road-map/

  2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Diseases Study 2010. Lancet 380:2163–2196

    Article  PubMed  Google Scholar 

  3. Zaki SM, Elkholy IM, Elkady NA, Abdelghany K (2014) Mucormycosis in Cairo, Egypt: review of 10 reported cases. Med Mycol 52(1):73–80

    CAS  PubMed  Google Scholar 

  4. Zaki SM, Ibrahim N, Aoyama K, Shetaia YM, Abdel-Ghany K, Mikami Y (2009) Dermatophyte infections in Cairo, Egypt. Mycopathologia 167:133–137

    CAS  Article  PubMed  Google Scholar 

  5. Shabrawy RM, Elbadawy NS, Harb AW (2013) The incidence of fungal keratitis in zagazig university hospitals, Egypt and the value of direct microscopy and PCR technique in rapid diagnosis. J Microbiol Infect Dis 3(4):186–191

    Article  Google Scholar 

  6. Moharram AM, Abdel-Kader MI, Al-Hussaini AK, Alghalibi SM (1999) Studies on mycotic keratitis in Assuit governorate. Proceedings of the Second International Conference on Fungi: Hopes & Challenges 1, pp 133–146

  7. Elias ML, Soliman AK, Mahoney FJ et al (2009) Isolation of Cryptococcus, candida, Aspergillus, Rhodotorula, and Nocardia from meningitis patients in Egypt. J Egypt Public Health Assoc 84(1&2):169–180

    PubMed  Google Scholar 

  8. Moharram AM, Abdel-Ati MG, Othman EO (2013) Vaginal yeast infection in patients admitted to Al-Azhar University Hospital, Assiut, Egypt. J Basic Appl Mycol 4:21–32

    Google Scholar 

  9. Zaki SM, Elkholy EM, Mohamed SS, Wasfy WM (2015) In-vitro susceptibility testing of dermatophytes isolated in Cairo, Egypt against eight antifungal agents by broth microdilution and disk diffusion methods. J Basic Appl Mycol 6:9–15

    Google Scholar 

  10. Elkholy EM, Zaki SM, Mohamed SS, Wasfy WM (2015) In vitro susceptibility testing of clinical zygomycetous species isolated in Cairo, Egypt against ten antifungal agents by broth microdilution, disk diffusion and E-test methods. Egyptian J Bot (accepted for publications)

  11. World Health Organisation (2011) World Health Statistics. http://www.who.int/gho/publications/world_health_statistics/en

  12. UNAIDS (2013) UNAIDS Global Report 2013. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en

  13. World Health Organisation (2014) Global tuberculosis report 2014. World Health Organisation, Geneva, 154pp

    Google Scholar 

  14. Arendrup MC (2010) Epidemiology of invasive candidiasis. Curr Opin Crit Care 16:445–452

    Article  PubMed  Google Scholar 

  15. Montravers F, Mira JP, Gangneux JP, Leroy OI, Lortholary O (2011) A multicenter study of antifungal strategies and outcomes of Candida peritonitis intensive care units. Clin Microbial Infect 17:1061–1067

    CAS  Article  Google Scholar 

  16. Matee MI, Scheutz F, Moshy J (2000) Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 6:106–111

    CAS  Article  PubMed  Google Scholar 

  17. Smith E, Orholm M (1990) Trends and patterns of opportunistic diseases in Danish AIDS patients 1980–1990. Scand J Infect Dis 22:665–672

    CAS  Article  PubMed  Google Scholar 

  18. Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM et al (2010) AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study. AIDS 24:1549–1559

    Article  PubMed  Google Scholar 

  19. Sobel JD (2007) Vulvovaginal candidosis. Lancet 369:1961–1971

    Article  PubMed  Google Scholar 

  20. Denning D, Pleuvry A, Cole D (2011) Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 89:864–872

    Article  PubMed  PubMed Central  Google Scholar 

  21. Polatli M, Kheder A, Wali S, Javed A, Khattab, A, Mahboub B, Iraqi G, Nejjari C, Taright S, Koniski M, Rashid N, El Hasnaoui A (2012) Chronic obstructive pulmonary disease and associated healthcare resource consumption in the middle east and north Africa: the breath study. 106(S2):S75–S85

  22. Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Peleaz T et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870–877

    CAS  Article  PubMed  Google Scholar 

  23. Xu H, Li L, Huang WJ, Wang LX, Li WF, Yuan WF (2012) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from china. Clin Microbiol Infect 18:403–408

    CAS  Article  PubMed  Google Scholar 

  24. Ben Abdella F, Taktak S, Chtourou A, Mahouachi R, Ben Kheder A (2011) Burden of chronic respiratory diseases (CRD) in Middle East and North Africa (MENA). WAO J 2011 supplement

  25. Al-Mobeireek AF, Gad MO, El-Rab SS, Al-Hedaithy A, Alasali K, Al-Majid S, Joharjy I (2001) Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir Med 95:341–347

    CAS  Article  PubMed  Google Scholar 

  26. Denning D, Pleuvry A, Cole D (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51:361–370

    Article  PubMed  Google Scholar 

  27. Yan X, Li M, Jiang M, Zou L, Luo F, Jiang Y (2009) Clinical characteristics of 45 patients with invasive pulmonary aspergillosis. Cancer 1:5018–5025

    Article  Google Scholar 

  28. Taj-Aldeen SJ, Chandra P, Denning DW (2015) Burden of fungal infections in Qatar. Mycoses 58(suppl S5):51–57

    Article  PubMed  Google Scholar 

  29. Sinko J, Sulyok M, Denning D (2015) Burden of serious fungal diseases in Hungary. Mycoses 58(Suppl S5):29–33

    Article  PubMed  Google Scholar 

  30. Denning DW, Pashley C, Harti D, Wardiaw A, Godet C, Del Giacco Delhaes L, Sergejeva S (2014) Fungal allergy in asthma—state of the art and research needs. Clin Transl Allergy 4:14

    Article  PubMed  PubMed Central  Google Scholar 

  31. Tageldin MA, Nafti S, Khan JA, Nejjari C, Beji M, Mahboub B et al (2012) Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATH study. Repair Med 106(Suppl 2):S25–S32

    Google Scholar 

  32. Denning DW, Perlin DS, Muldoon EG, Colombo AL, Chakrabarti A, Richardson MD, Sorrell TC (2016) Delivering on the Antimicrobial Resistance (AMR) agenda is not possible without improving fungal diagnostic capabilities. Emerg Infect Dis. In press

Download references

Author information

Affiliations

  1. Mycology Unit, Microbiology Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, 11566, Egypt

    S. M. Zaki

  2. The University of Manchester and National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester, Manchester, UK

    D. W. Denning

Authors
  1. S. M. Zaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. W. Denning
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. M. Zaki.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zaki, S.M., Denning, D.W. Serious fungal infections in Egypt. Eur J Clin Microbiol Infect Dis 36, 971–974 (2017). https://doi.org/10.1007/s10096-017-2929-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-017-2929-4

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Candidiasis
  • Invasive Aspergillosis
  • Fungal Disease
  • Cryptococcal Meningitis